Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Treatment With Ultra-low Dose Subcutaneous IL-2 to Promote Regulatory T Cells Post Renal Transplantation

NCT02417870 is registered in ClinicalTrials.gov with Anil K. Chandraker, MD as lead sponsor.

NCT NCT02417870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02417870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Treatment With Ultra-low Dose Subcutaneous IL-2 to Promote Regulatory T Cells Post Renal Transplantation
Lead sponsor
Anil K. Chandraker, MD
Phase
Phase 1/2
Overall status
Terminated
Start date
September 30, 2015
Completion date
April 30, 2018
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation